Xpress Biologics Overview
- Status
- Private
- Employees
- 2
- Latest Deal Type
- Early Stage VC
- Latest Deal Amount
- $715K
- Investors
- 3
Xpress Biologics General Information
Description
Operator of a contract manufacturing systems designed to provide services for pre-clinical productions. The company's systems include the design of microbial expression services, the development of the upstream and downstream processes, and the development of the quality controls for the production of recombinant proteins, antibody fragments, and plasmid DNA, enabling the vaccine, therapeutic and diagnostic markets to execute and manage clinical trials.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
- Accessia Pharma site
- Avenue du Parc Industriel, 89, Milmort
- 4041 Herstal
- Belgium
+32 04 000 00 00
Xpress Biologics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 22-Dec-2016 | $715K | 00.000 | 00.000 | Completed | Generating Revenue |
| 2. Early Stage VC | 14-Aug-2015 | 00000 | 00000 | 00000 | Completed | Generating Revenue |
| 1. Accelerator/Incubator | 01-Feb-2013 | Completed | Startup |
Xpress Biologics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class C | 0,000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | ||
| Class B | 0,000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | ||
| Class A | 000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | ||
| Class C | 000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | ||
| Class B | 1,300 | $105.64 | $105.64 | 1x | $105.64 | 9.26% | ||
| Class A | 1,211 | $105.64 | $105.64 | 1x | $105.64 | 8.63% |
Xpress Biologics Executive Team (3)
Xpress Biologics Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Christian Rodriguez Ph.D | Xpress Biologics | Co-Founder, Operation Director & Board Member | 000 0000 |
| Philippe Ledent Ph.D | Xpress Biologics | Co-Founder, Board Member & Scientific Director | 000 0000 |
Xpress Biologics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialXpress Biologics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| BioWin | Corporation | Minority | 000 0000 | 000000 0 | |
| Noshaq | Venture Capital | Minority | 000 0000 | 000000 0 | |
| WBC Ventures | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |